Potential Price Increase for Amphastar Pharmaceuticals Inc. (AMPH) After Recent Insider Activity


Amphastar Pharmaceuticals Inc.’s recent filing unveils that its EVP Corp Admin Center Liawatidewi Yakob unloaded Company’s shares for reported $1.53 million on Aug 28. In the deal valued at $53.13 per share,28,816 shares were sold. As a result of this transaction, Liawatidewi Yakob now holds 69,669 shares worth roughly $ 3.8 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, PRINS RICHARD K sold 2,000 shares, generating $105,006 in total proceeds. Upon selling the shares at $52.50, the Director now owns 40,895 shares.

Before that, ZASLOFF MICHAEL A sold 12,759 shares. Amphastar Pharmaceuticals Inc. shares valued at $730,025 were divested by the Director at a price of $57.22 per share. As a result of the transaction, ZASLOFF MICHAEL A now holds 33,826 shares, worth roughly $1.84 million.

PT values the company’s stock at a premium of 22.1 to its Friday closing price.

Price Performance Review of AMPH

On Friday, Amphastar Pharmaceuticals Inc. [NASDAQ:AMPH] saw its stock jump 2.29% to $54.53. On the same session, the stock had its day’s lowest price of $53.71, but rose to a high of $55.435. Over the last five days, the stock has gained 2.89%. Amphastar Pharmaceuticals Inc. shares have risen nearly 94.61% since the year began. Nevertheless, the stocks have risen 84.22% over the past one year. While a 52-week high of $67.66 was reached on 08/09/23, a 52-week low of $26.76 was recorded on 01/05/23. SMA at 50 days reached $57.43, while 200 days put it at $41.18. A total of 0.21 million shares were traded, compared to the trading of 0.23 million shares in the previous session.

Levels Of Support And Resistance For AMPH Stock

The 24-hour chart illustrates a support level at 53.68, which if violated will result in even more drops to 52.83. On the upside, there is a resistance level at 55.41. A further resistance level may holdings at 56.28. The Relative Strength Index (RSI) on the 14-day chart is 46.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.67%. Stochastics %K at 29.61% indicates the stock is a holding.

How much short interest is there in Amphastar Pharmaceuticals Inc.?

A steep rise in short interest was recorded in Amphastar Pharmaceuticals Inc. stocks on Aug 14, 2023, dropping by -0.58 million shares to a total of 1.49 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 2.07 million shares. There was a decline of -38.93%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 4.78% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.5.

Amphastar Pharmaceuticals Inc. [AMPH] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 5,558,046 shares, or roughly 11.51% of the outstanding AMPH shares. In other words, the investor’s shares have fallen by -239,886 from its previous 13-F filing of 5797932.0.. Over the last quarter, Dimensional Fund Advisors LP purchased 13,044 shares of Amphastar Pharmaceuticals Inc., while Neuberger Berman Investment Advis bought 1,059,032 shares. At present, SSgA Funds Management, Inc. is holding 1,394,504 shares valued at $84.63 million. Fuller & Thaler Asset Management, owned 1,279,495 shares of the company at the time of its most recent 13F filing, worth $77.65 million.

According to FactSet, Amphastar Pharmaceuticals Inc.’s share price will average $69.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 31.31 percent from its previous closing price of $53.31. Analysts expect Amphastar Pharmaceuticals Inc. stock to reach the higher price of $71.00, while the lowest price estimate is $66.00. However, 4 analysts have rated AMPH stock as an Overweight in their predictions for 2023.


Please enter your comment!
Please enter your name here